Formidable Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Formidable Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$0.28 - $1.16 $560 - $2,320	-2,000 Reduced 4.52%	42,288 $13,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $861 - $1,357	813 Added 1.87%	44,288 $51,000
Q4 2023 Feb 07, 2024	BUY	$1.26 - $1.79 $24,558 - $34,888	19,491 Added 81.27%	43,475 $73,000
Q3 2023 Nov 09, 2023	BUY	$1.61 - $2.54 $3,542 - $5,588	2,200 Added 10.1%	23,984 $43,000
Q2 2023 Aug 15, 2023	BUY	$1.14 - $1.95 $1,311 - $2,242	1,150 Added 5.57%	21,784 $41,000
Q1 2023 May 09, 2023	BUY	$1.2 - $2.19 $330 - $602	275 Added 1.35%	20,634 $27,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $19 - $100	27 Added 0.13%	20,359 $56,000
Q2 2022 Aug 16, 2022	BUY	$2.2 - $4.2 $10,881 - $20,773	4,946 Added 32.15%	20,332 $64,000
Q1 2022 May 04, 2022	BUY	$2.83 - $8.69 $43,542 - $133,704	15,386 New	15,386 $62,000
Q4 2021 Feb 07, 2022	SELL	$8.31 - $14.92 $500,993 - $899,496	-60,288 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$9.15 - $13.28 $551,635 - $800,624	60,288 New	60,288 $699,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Formidable Asset Management, LLC with notifications on news.